Muge N. Kuyumcu‐Martinez

This paper uses a computational framework to identify FDA-approved drugs that can promote cardiomyocyte proliferation, finding lithium as a potential therapeutic but highlighting congenital risks.

This study reports the discovery of using antisense oligonucleotides (ASOs) to rescue the biallelic SEL1L C141Y variant, offering a potential therapeutic strategy.

This study identifies RBFOX2's role in maintaining alternative polyadenylation and mitochondrial health in rat myoblasts, linking it to heart disease pathology.